United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Pharma Industry News PharmaMar’s lurbinectedin granted orphan drug designation by FDA for small cell lung cancer treatment Spanish pharmaceutical company PharmaMar has announced that its cancer drug, lurbinectedin, has received orphan drug designation from the… bypharmanewsdailyAugust 5, 2018
